China NT Pharma Group Company Limited (HKG:1011)

Hong Kong · Delayed Price · Currency is HKD

0.5400

-0.0200 (-3.57%)

Jun 1, 2026, 3:58 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Proprietary Products Production and Sales			7.37M		226.70M	221.73M	153.47M	307.67M
Proprietary Products Production and Sales Growth			-		2.24%	44.48%	-50.12%	-17.40%
Miacalcic			-		-	-	-	263.86M
Miacalcic Growth			-		-	-	-	13.54%
Total			7.37M		226.70M	221.73M	153.47M	571.52M
Total Growth			-		2.24%	44.48%	-73.15%	-5.51%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
PRC (Excl. Hong Kong)			7.37M		226.70M	221.73M	153.47M	539.61M
PRC (Excl. Hong Kong) Growth			-		2.24%	44.48%	-71.56%	-5.50%
Hong Kong			-		-	-	-	4.85M
Other Countries			-		-	-	-	27.07M
Other Countries Growth			-		-	-	-	-19.98%
Total			7.37M		226.70M	221.73M	153.47M	571.52M
Total Growth			-		2.24%	44.48%	-73.15%	-5.51%

Source: S&P Global Market Intelligence.